Key facts
- This page summarizes Marshman Fund Trust II's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Nov 2024, 16:05.
Marshman Fund Trust II - 01 Nov 2024 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- HRMY
- Reported as of
- 01 Nov 2024
- Net transaction value
- -$139,391,500
- Reporting owner signature
- /s/ Charles Harris, Co-Trustee
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Marshman Fund Trust II filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 05 Nov 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$139,391,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HRMY
transaction
Common Stock
Sale
- Transaction value
- $121,210,000
- Shares
- -4,000,000
- Change %
- -38%
- Price
- $30.30
- Shares after
- 6,651,120
- Date
- 01 Nov 2024
- Ownership
- Direct
HRMY
transaction
Common Stock
Sale
- Transaction value
- $18,181,500
- Shares
- -600,000
- Change %
- -9%
- Price
- $30.30
- Shares after
- 6,051,120
- Date
- 05 Nov 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.